Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00111878 · ClinicalTrials.gov registry record
Study to Evaluate MEDI-534 in Healthy Adults
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 120
- Enrollment target
NCT00111878 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 120 participants.
The verdict
NCT00111878 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The primary objective of this study is to describe the safety and tolerability of a single dose of MEDI-534 when administered to healthy adult volunteers.
Interventions
- DRUG MEDI-534
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2005-04 |
| Est. Completion | 2005-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00111878
The ClinicalTrials.gov registry entry for NCT00111878 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MEDI-534 is the first listed.
NCT00111878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00111878 about?
NCT00111878 is a clinical study titled "Study to Evaluate MEDI-534 in Healthy Adults". The primary objective of this study is to describe the safety and tolerability of a single dose of MEDI-534 when administered to healthy adult volunteers.
What is the current status of trial NCT00111878?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2005-04. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00111878?
The interventions under investigation include: MEDI-534 (DRUG).
Who is sponsoring clinical trial NCT00111878?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.